טוען...
Emerging Variants of Castration-Resistant Prostate Cancer
Metastatic castration resistant prostate cancer (CRPC) is associated with substantial clinical, pathologic, and molecular heterogeneity. Most tumors remain driven by androgen receptor (AR) signaling, which has clinical implications for patient selection for AR-directed approaches. However, histologi...
שמור ב:
| הוצא לאור ב: | Curr Oncol Rep |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5479409/ https://ncbi.nlm.nih.gov/pubmed/28361223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-017-0593-6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|